Oxford University, AstraZeneca begin advanced trials of coronavirus vaccine

• As part of the procedure, the trial will expand the age range of testing to children from 5 to 12 years old and adults 56 and older.
• Adults will be randomly chosen to receive one or two doses of an already licensed vaccine against meningococcus for comparison.
• AstraZeneca has agreed to initially supply at least 400 million doses of the vaccine and secured total manufacturing capacity to produce 1 billion doses.

(Karachi) The Oxford University and AstraZeneca Pls, a British-Swedish drugmaker, have started the process of recruiting more than 10,000 people for advanced human studies to conduct experiments on Covid-19 vaccines, Bloomberg reported.

As part of the procedure, the trial will expand the age range of testing to children from 5 to 12 years old and adults 56 and older. The other, larger stage will test the vaccine’s effectiveness in volunteers 18 and older.

https://twitter.com/business/status/1263750966429523969

Recently, AstraZeneca received funding worth 1.2 billion dollars from United States for its efforts to get the immunization tested and ready for use.

Adults will be randomly chosen to receive one or two doses of an already licensed vaccine against meningococcus for comparison.